Analytical advances in horseracing medication and doping control from 2018 to 2023
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3760 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Bob Gray und 5 weiteren Autor:innen. Beteiligte Einrichtung: LGC Ltd, Cambridgeshire, UK. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Performance-Enhancing Substances. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 312 Literaturangaben.
Abstract (Originalsprache)
The analytical approaches taken by laboratories to implement robust and efficient regulation of horseracing medication and doping control are complex and constantly evolving. Each laboratory's approach will be dictated by differences in regulatory, economic and scientific drivers specific to their local environment. However, in general, laboratories will all be undertaking developments and improvements to their screening strategies in order to meet new and emerging threats as well as provide improved service to their customers. In this paper, the published analytical advances in horseracing medication and doping control since the 22nd International Conference of Racing Analysts and Veterinarians will be reviewed. Due to the unprecedented impact of COVID‐19 on the worldwide economy, the normal 2‐year period of this review was extended to over 5 years. As such, there was considerable ground to cover, resulting in an increase in the number of relevant publications included from 107 to 307. Major trends in publications will be summarised and possible future directions highlighted. This will cover developments in the detection of ‘small’ and ‘large’ molecule drugs, sample preparation procedures and the use of alternative matrices, instrumental advances/applications, drug metabolism and pharmacokinetics, the detection and prevalence of ‘endogenous' compounds and biomarker and OMICs approaches. Particular emphasis will be given to research into the potential threat of gene doping, which is a significant area of new and continued research for many laboratories. Furthermore, developments in analytical instrumentation relevant to equine medication and doping control will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LGC Ltd, Cambridgeshire, UK.
ORCID-Profile: Bob Gray, Edward Ryder
Zitieren
APA
Gray, B., Lubbock, K., Love, C., Ryder, E., Hudson, S., & Scarth, J. (2025). Analytical advances in horseracing medication and doping control from 2018 to 2023. Drug Testing and Analysis. https://doi.org/10.1002/dta.3760
Vancouver
Gray B, Lubbock K, Love C, Ryder E, Hudson S, Scarth J. Analytical advances in horseracing medication and doping control from 2018 to 2023. Drug Testing and Analysis. 2025. doi:10.1002/dta.3760
BibTeX
@article{Gray2025,
author = {Gray, Bob and Lubbock, Katy and Love, Catherine and Ryder, Edward and Hudson, Simon and Scarth, James},
title = {Analytical advances in horseracing medication and doping control from 2018 to 2023},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3760}
}
EUVIMED